These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12871688)

  • 21. Prognostic significance of creatine kinase-MB elevation after percutaneous coronary intervention in patients with chronic renal dysfunction.
    Jeremias A; Albirini A; Ziada KM; Chew DP; Brener SJ; Topol EJ; Ellis SG
    Am Heart J; 2002 Jun; 143(6):1040-5. PubMed ID: 12075261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study.
    Cavallini C; Savonitto S; Violini R; Arraiz G; Plebani M; Olivari Z; Rubartelli P; Battaglia S; Niccoli L; Steffenino G; Ardissino D;
    Eur Heart J; 2005 Aug; 26(15):1494-8. PubMed ID: 15741227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non-ST-elevation acute coronary syndromes.
    Kleiman NS; Lakkis N; Cannon CP; Murphy SA; DiBattiste PM; Demopoulos LA; Weintraub WS; Braunwald E;
    J Am Coll Cardiol; 2002 Sep; 40(6):1044-50. PubMed ID: 12354426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of recurrent episodes of creatine kinase-MB elevation following repeated catheter-based coronary interventions.
    Kornowski R; Fuchs S; Hong MK; Mehran R; Satler LF; Pichard AD; Kent KM; Stone GW; Leon MB
    Catheter Cardiovasc Interv; 2000 Oct; 51(2):131-7. PubMed ID: 11025563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical detection of minor myocardial injury after elective, uncomplicated, successful percutaneous coronary intervention in patients with stable angina: clinical outcome.
    Saadeddin SM; Habbab MA; Sobki SH; Ferns GA
    Ann Clin Biochem; 2002 Jul; 39(Pt 4):392-7. PubMed ID: 12117443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Timing of peak troponin T and creatine kinase-MB elevations after percutaneous coronary intervention.
    Miller WL; Garratt KN; Burritt MF; Reeder GS; Jaffe AS
    Chest; 2004 Jan; 125(1):275-80. PubMed ID: 14718451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence and determinants of myocardial infarction following percutaneous coronary interventions according to the revised Joint Task Force definition of troponin T elevation.
    Alcock RF; Roy P; Adorini K; Lau GT; Kritharides L; Lowe HC; Brieger DB; Freedman SB
    Int J Cardiol; 2010 Apr; 140(1):66-72. PubMed ID: 19131135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of different cardiac markers in monitoring percutaneous coronary interventions with frequent use of stents and gpIIbIIIa-antagonists.
    Mark B; Schneider S; Schiele R; Taubert G; Kilkowski C; Seidl K; Nagel D; Seiler D; Senges J; Zahn R
    Z Kardiol; 2003 Dec; 92(12):1018-24. PubMed ID: 14663612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of troponin T, troponin I, and CK-MBmass in patients with chronic renal failure.
    Peetz D; Schütt S; Sucké B; Faldum A; Wandel E; Hafner G; Lackner KJ
    Med Klin (Munich); 2003 Apr; 98(4):188-92. PubMed ID: 12715142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship of serum cardiac markers following successful percutaneous coronary intervention and subsequent exercise capacity in patients with chronic stable angina: a pilot study.
    Williams SG; Stables RH; Wright DJ; Taylor S; Thompson D; Tan LB
    Cardiology; 2005; 103(2):63-7. PubMed ID: 15539783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Chia S; Senatore F; Raffel OC; Lee H; Wackers FJ; Jang IK
    JACC Cardiovasc Interv; 2008 Aug; 1(4):415-23. PubMed ID: 19463339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence and impact on prognosis of peri-procedural myocardial infarction in 2760 elective patients with stable angina pectoris in a historical prospective follow-up study.
    Christensen MK; Huang H; Torp-Pedersen C; Trydal T; Ravkilde J
    BMC Cardiovasc Disord; 2016 Jun; 16():140. PubMed ID: 27305902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of human heart-type fatty acid-binding protein as an early diagnostic biochemical marker of myocardial necrosis in patients with acute coronary syndrome, and its comparison with troponin-T and creatine kinase-myocardial band.
    Ruzgar O; Bilge AK; Bugra Z; Umman S; Yilmaz E; Ozben B; Umman B; Meric M
    Heart Vessels; 2006 Sep; 21(5):309-14. PubMed ID: 17151819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Occurrence of non-Q wave myocardial infarction following percutaneous coronary intervention in the stent era: systematic monitoring of the three markers of myocardial necrosis.
    Varani E; Balducelli M; Vecchi G; Gatti C; Lucchi GR; Maresta A
    J Interv Cardiol; 2005 Aug; 18(4):243-8. PubMed ID: 16115152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multicentre evaluation of the diagnostic value of cardiac troponin T, CK-MB mass, and myoglobin for assessing patients with suspected acute coronary syndromes in routine clinical practice.
    Collinson PO; Stubbs PJ; Kessler AC;
    Heart; 2003 Mar; 89(3):280-6. PubMed ID: 12591831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of the high-sensitivity troponin T assay after percutaneous intervention of chronic total occlusions.
    Cottens D; Maeremans J; McCutcheon K; Lamers S; Roux L; Duponselle J; Bennett J; Dens J
    J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):366-372. PubMed ID: 29877975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of elevated troponin I after percutaneous coronary intervention.
    Cantor WJ; Newby LK; Christenson RH; Tuttle RH; Hasselblad V; Armstrong PW; Moliterno DJ; Califf RM; Topol EJ; Ohman EM;
    J Am Coll Cardiol; 2002 Jun; 39(11):1738-44. PubMed ID: 12039485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Death following creatine kinase-MB elevation after coronary intervention: identification of an early risk period: importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy.
    Ellis SG; Chew D; Chan A; Whitlow PL; Schneider JP; Topol EJ
    Circulation; 2002 Sep; 106(10):1205-10. PubMed ID: 12208794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The FRISC experience with troponin T. Use as decision tool and comparison with other prognostic markers.
    Lindahl B; Venge P; Wallentin L
    Eur Heart J; 1998 Nov; 19 Suppl N():N51-8. PubMed ID: 9857941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reporting.
    Vranckx P; Farooq V; Garg S; Van Es GA; Silber S; Windecker S; Stone GW; Serruys PW
    Heart; 2012 Oct; 98(19):1424-30. PubMed ID: 22821273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.